SAXE JON S 4
4 · VistaGen Therapeutics, Inc. · Filed Aug 24, 2020
Insider Transaction Report
Form 4
SAXE JON S
Director
Transactions
- Purchase
Common Stock
2020-08-21$0.69/sh+30,000$20,700→ 50,000 total(indirect: By Trust)
Holdings
- 3,251
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.678 to $0.697, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form